comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-29 22:53:32 - browse：94882

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

Paul Marchetti, the head of insurer Elevance Health’s pharmacy benefit manager, has left the company amid a wave of consumer complaints about patients receiving incorrect medicines or being unable to get their prescriptions filled.

Elevance did not confirm Marchetti’s departure as the president of CarelonRx, but according to his Linkedin profile, he left the company in May.

Elevance, the second-largest commercial health insurer in the country by market share, uses its CarelonRx subsidiary to manage its pharmacy business. In online complaints, CarelonRx customers point toward January 1 as the date when issues with obtaining their prescriptions from the company began. The reported problems include safety issues like receiving other people’s medications or receiving medications they discontinued years ago.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： The creative science of coining drug names

WSS

GSK’s asthma push continues as drug succeeds in Phase 3 trials

As billionaires fund anti

Has Bernie Sanders reached the limit of his pharma bullying effort?

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

The effects of a landmark ruling on DNA ownership are becoming clearer

BIO to announce reorganization, senior leaders expected to depart

explore

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

hotspot

Jerome Adams on the need for new antivirals for Covid

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

Anesthesiologist group: stop taking Ozempic before surgery

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Duchenne breakthrough therapy leaves behind pioneering families

Kansas bar where gunfire wounded 9 last month closes permanently

Cancer drug shortages should be causing more outrage

As health system earnings go up, health insurance stocks go down

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

GSK’s asthma push continues as drug succeeds in Phase 3 trials

focus

Primary care doctor shortage won't be solved by free med school tuition

Sage considers ways to reduce costs following FDA rejection

Trump used to be more articulate. What could explain the change?

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

Failure, not just success, should guide future doctors

AltruBio raises $225 million to develop ulcerative colitis drug

focus

explore

Wikipedia

leisure time